Delivery Order SPE2DB20D1100-SPE2DB24FC7Z1

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for NALBUPHINE 200 MG/10 ML VIAL 10ML, a pain management medication. The total ceiling value is $4,266.65, with a firm fixed price pricing type. The ultimate completion date is June 24, 2024. This contract is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,366.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML medical supplies, with a performance period ending on December 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,887.80 and a completion date of February 3, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This contract award to Amerisourcebergen Drug Corp (AmerisourceBergen) is for the supply of NALBUPHINE 200 MG/10 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order (SPE2DB20D3103|SPE2DB24FQ0Y4) with a firm-fixed price of $4,972.71 and a completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not set aside. The contract is part of a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,824.74 firm fixed price contract is for the supply of 4564604895 - NALBUPHINE 200 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp, headquartered in Conshohocken, PA, is a major supplier of pharmaceutical products and...
This federal contract award, valued at $3,498.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a performance period ending on December 20, 2024. The contract is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is to provide 4,564,202,701 units of 200 mg/10 mL nalbuphine vials with a completion date of April 9, 2024. The contract has a ceiling value of $1,864.20 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor for DLA, holding an indefinite delivery contract...
This federal contract award is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract was awarded to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,271.25 and is a Firm Fixed Price Delivery Order with a completion date of November 1, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nalbuphine 100 mg/10 mL vials. The award, with a ceiling value of $2,946.07, is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,248.06 firm fixed-price contract is for the supply of the prescription medication nalbuphine hydrochloride in 10 mL vials. The contract has a completion date of September 18, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC7Z1
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NALBUPHINE 200 MG/10 ML VIAL 10ML. The contract has a ceiling value of $1,824.74 and an ultimate completion date of July 18, 2024. This contract is not associated with any set-aside program. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors. The DLA is the funding agency for this contract, which is part of the agency's efforts to procure essential pharmaceutical and medical supplies to support military treatment programs and facilities worldwide.

Generated 10/16/24, 9:09 AM